BCL6-IN-6

CAS No. 2408882-54-0

BCL6-IN-6( —— )

Catalog No. M28485 CAS No. 2408882-54-0

BCL6-IN-6 is an inhibitor of Bcl-6 and can be used in studies about diffuse large B-cell lymphoma. BCL6-IN-6 blocks the interaction of Bcl-6 with its corepressors and dose-dependently reactivates Bcl-6 target genes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 98 In Stock
10MG 170 In Stock
25MG 271 In Stock
50MG 379 In Stock
100MG 509 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BCL6-IN-6
  • Note
    Research use only, not for human use.
  • Brief Description
    BCL6-IN-6 is an inhibitor of Bcl-6 and can be used in studies about diffuse large B-cell lymphoma. BCL6-IN-6 blocks the interaction of Bcl-6 with its corepressors and dose-dependently reactivates Bcl-6 target genes.
  • Description
    BCL6-IN-6 is an inhibitor of Bcl-6 and can be used in studies about diffuse large B-cell lymphoma. BCL6-IN-6 blocks the interaction of Bcl-6 with its corepressors and dose-dependently reactivates Bcl-6 target genes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    Bcl-2
  • Recptor
    SARS-CoV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2408882-54-0
  • Formula Weight
    522.64
  • Molecular Formula
    C27H31FN6O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 4 mg/mL (7.65 mM)
  • SMILES
    N(C1=NC(=NC=C1F)N2C[C@H](C)N[C@H](C)C2)C3=CC(OC)=C(NC(=O)C=4SC(=CC4)C=5CCCC5)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Paederosidic acid

    Paederosidic acid has significant anti-tumor anticonvulsant and sedative effects. Paederosidic acid increases brain gamma-aminobutyric acid and decreases glutamic acid in the brain and it up-regulates expressions of GAD 65 may be a promising future therapeutic agent for treatment of epilepsy.

  • Bim BH3, Peptide IV

    This Bim peptide belongs to the pro-apoptotic group of the Bcl-2 family of proteins.

  • ML311

    ML311 is a selective inhibitor of the Mcl-1/Bim interaction.